Opinion · 2 Dec 2025
Research articlePublished 2014
G4.5 Pamam Dendrimer-Risperidone: Biodistribution and Behavioral Changes in In Vivo Model
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Dendritic polymers are considered as emerging and outstanding carriers as modern medicinal systems due to their derivatisable branched architecture and possibility to modify them in numerous ways. Here, G4.5 PAMAM dendrimers were obtained as carriers of the antipsychotic drug risperidone. Despite their extensive applicability in the pharmaceutical field, the use of dendrimers as carriers in biological systems is constrained due to their inherent associated toxicity. The biocompatibility of dendrimers and dendrimer-risperidone complexes was evaluated in vivo for biological performance. To this end, the pharmacokinetics and biodistribution after oral treatment of free risperidone and dendrimer-risperidone complexes were studied in healthy mice. Also, the behavioral changes such as locomotion, aggression, dominance in male and female mice were evaluated both after a single dose and after daily therapy for 8 days. Also, in vivo effects of risperidone and dendrimer-risperidone complexes on the locomotion of zebrafish larvae were explored. The data obtained suggest that the unmetabolized risperidone complexes increase the arrival to the brain after 90 minutes. On the other hand, behavioral studies showed an increase in the potency of the drug in animals treated with the complexes.
Keywords
Subjects
NanotechnologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of Nanomedicine & Biotherapeutic Discovery.
Review article · 20 Jun 2025
Metal Nanoparticles in Medicine: Biosynthesis and Applications in Chemotherapy, Drug Delivery, and Anticancer, Antibacterial and Antioxidant Chemical Production
Research article · 28 Apr 2025
A Novel Chemical Entity, that Reverses Warburg Metabolism by Disrupting VDAC1/HK2 Interaction through
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Nanomedicine & Biotherapeutic Discovery
- SubjectNanotechnology
- BylineArticles whose byline prints “Maria Jimena Prieto”
- BylineArticles whose byline prints “Nahuel Eduardo del Rio Zabala”
- BylineArticles whose byline prints “Cristian Hernán Marotta”
- BylineArticles whose byline prints “Dario Bichara”
- BylineArticles whose byline prints “Sergio Simonetta”
- BylineArticles whose byline prints “Nadia Silvia Chiaramoni”
- BylineArticles whose byline prints “Silvia del Valle Alonso”
